• Slider Image
  • Slider Image
  • Slider Image

Sickle Cell Education Centre

Obtain free access to past, current and future editions of SICKLE CELL NEWS.

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of SCD

Modus Therapeutics AB, a company developing innovative treatments in disease areas with high unmet medical need with a focus on sickle cell disease (SCD), announces that the FDA has accepted its sevuparin IND for the treatment of SCD. “The FDA’s decision to accept the IND application for the development of sevuparin in sickle cell disease…

PLACE YOUR ADVERTS ON OUR MAGAZINES

We offer pocket friendly advert rates.

grandpashabet girişgrandpashabet girişdeneme bonusudeneme bonusu veren bahis sitelerideneme bonusu 2026grandpashabet girişGrandpashabetgrandpashabetgrandpashabet deneme bonusugrandpashabet deneme bonusudeneme bonusuGrandpashabetgrandpashabet girişgrandpashabetgrandpashabet güncel girişbahis siteleribahis siteleriGrandpashabet girişjojobetjojobet girişjojobetjojobet girişjojobet girişjojobetjojobet